Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report

BACKGROUND: To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been designed. It has been noted in vitro that upon exposure to these treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenaux, Honorine, Gueneau, Romain, Chaghouri, Amal, Henry, Benoît, Mouna, Lina, Roque-Afonso, Anne-Marie, Vauloup-Fellous, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649676/
https://www.ncbi.nlm.nih.gov/pubmed/34876033
http://dx.doi.org/10.1186/s12879-021-06902-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649676/
https://www.ncbi.nlm.nih.gov/pubmed/34876033
http://dx.doi.org/10.1186/s12879-021-06902-1

Ejemplares similares